Who should discuss the risks and benefits of renal replacement therapies with the client?

• A. The healthcare provider (HCP).
• B. The nurse.
• C. The pharmacist.
• D. The family.],

Answer: (A)

The situation tests who should lead the discussion about risks and benefits of renal replacement therapies. That discussion requires medical expertise to explain what each option involves, the expected outcomes, potential complications, and how it fits with the patient’s overall health and goals. This is essential for informed decision-making and consent, so the healthcare provider is best suited to have the thorough risk–benefit conversation with the client. The nurse can reinforce information and support the patient as questions arise, but the formal risk–benefit discussion and consent are led by the clinician. The pharmacist focuses on medication-related considerations, and the family provides support, but they’re not the primary source for this critical educational discussion unless the patient cannot participate.